Načítá se...

P11.46 Discovery of a new HDAC6 inhibitor for the treatment of glioblastoma

BACKGROUND: Glioblastoma’s origin and development is not only associated to genetic alterations, but also to epigenetic changes. Indeed, an altered expression or activity of epigenetic enzymes such as histone deacetylases (HDAC) has been associated to cancer stem cell activity, which has been widely...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Auzmendi-Iriarte, J, Saenz-Antoñanzas, A, Andermatten, J, Elua-Pinin, A, Aldaba, E, Vara, Y, Matheu, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.192
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!